IceCure Medical Ltd
ICCM
$0.71
-$0.01-0.70%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -48.07% | -30.28% | 102.45% | 7.90% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -48.07% | -30.28% | 102.45% | 7.90% | |
| Cost of Revenue | -18.09% | -33.24% | 22.00% | -4.37% | |
| Gross Profit | -75.28% | -26.71% | 1,121.74% | 22.12% | |
| SG&A Expenses | -16.94% | 54.55% | 40.16% | -10.80% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -7.76% | 15.63% | 11.35% | -15.52% | |
| Operating Income | -4.86% | -32.50% | -4.12% | 20.90% | |
| Income Before Tax | -9.19% | -49.55% | -3.73% | 20.78% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -9.19% | -49.55% | -3.73% | 20.78% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -9.19% | -49.55% | -3.73% | 20.78% | |
| EBIT | -4.86% | -32.50% | -4.12% | 20.90% | |
| EBITDA | -5.63% | -33.34% | -4.18% | 21.39% | |
| EPS Basic | 8.90% | -21.95% | 8.67% | 26.17% | |
| Normalized Basic EPS | 8.91% | -21.95% | -- | 26.27% | |
| EPS Diluted | 8.90% | -21.95% | 8.67% | 26.17% | |
| Normalized Diluted EPS | 8.91% | -21.95% | -- | 26.27% | |
| Average Basic Shares Outstanding | 19.82% | 22.62% | 13.52% | 7.33% | |
| Average Diluted Shares Outstanding | 19.82% | 22.62% | 13.52% | 7.33% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |